Haemonetics Corp. buy Needham & Company LLC
Start price
08.05.25
/
50%
€60.00
Target price
08.05.26
€74.16
Performance (%)
5.00%
Price
14.01.26
€65.50
Summary
This prediction is currently active. The BUY prediction by Needham___Company_LL shows slight gains of 5.00%. This prediction currently runs until 08.05.26. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Haemonetics Corp. | -9.655% | -9.655% |
| iShares Core DAX® | 0.336% | 4.366% |
| iShares Nasdaq 100 | 0.541% | 3.170% |
| iShares Nikkei 225® | 4.048% | 6.727% |
| iShares S&P 500 | 0.795% | 3.281% |
Comments by Needham___Company_LL for this prediction
In the thread Haemonetics Corp. diskutieren
Haemonetics Co. (NYSE: HAE) had its price target lowered by analysts at Needham & Company LLC from $104.00 to $84.00. They now have a "buy" rating on the stock.
Ratings data for HAE provided by MarketBeat
Stopped prediction by Needham___Company_LL for Haemonetics Corp.
Haemonetics Corp.
Start price
Target price
Perf. (%)
€49.00
07.08.25
07.08.25
€58.31
07.08.26
07.08.26
28.57%
14.01.26
14.01.26
Haemonetics Corp.
Start price
Target price
Perf. (%)
€57.00
07.02.25
07.02.25
€104.18
07.02.26
07.02.26
10.53%
14.01.26
14.01.26
Haemonetics Corp.
Start price
Target price
Perf. (%)
€80.50
03.12.24
03.12.24
€106.36
03.12.25
03.12.25
-14.29%
04.12.25
04.12.25
Haemonetics Corp.
Start price
Target price
Perf. (%)
€84.00
15.11.24
15.11.24
€106.41
15.11.25
15.11.25
-25.60%
16.11.25
16.11.25
Haemonetics Corp.
Start price
Target price
Perf. (%)
€79.00
12.06.24
12.06.24
€103.42
12.06.25
12.06.25
-24.68%
13.06.25
13.06.25